malignant solid neoplasm

Showing 51 - 75 of 168

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nutritional Interventions Among Cancer Patients

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Interview
  • Survey Administration
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Dec 13, 2022

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Malignant Solid Tumor Trial (Biospecimen Collection, Cryocompression Therapy, Pneumatic Compression Therapy)

Not yet recruiting
  • Malignant Solid Neoplasm
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Nov 30, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Identifying Malnutrition in Older Cancer Participants

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Comprehensive Geriatric Assessment
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Adult Liver Carcinoma, Gastric Carcinoma, Malignant Solid Tumor Trial in Columbus (other, behavioral, procedure)

Recruiting
  • Adult Liver Carcinoma
  • +3 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 23, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Memphis, Seattle (Behavioral Intervention, Survey

Enrolling by invitation
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Behavioral Intervention
  • Survey Administration
  • Memphis, Tennessee
  • +1 more
Nov 18, 2022

l Empathy of Healthcare Practitioners From Department of

Active, not recruiting
  • COVID-19 Infection
  • +2 more
  • Best Practice
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • (no location specified)
Nov 8, 2022

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

National Cancer Institute "Cancer Moonshot Biobank"

Recruiting
  • Acute Myeloid Leukemia
  • +33 more
  • Biospecimen Collection
  • Medical Chart Review
  • Kingman, Arizona
  • +99 more
Nov 3, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Sleep Disorder Trial in Houston (other, drug, procedure)

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Counseling
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients

Recruiting
  • COVID-19 Infection
  • +2 more
  • Quality-of-Life Assessment
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Project: Every Child for Younger Patients With Cancer

Recruiting
  • Carcinoma In Situ
  • +10 more
  • Cytology Specimen Collection Procedure
  • Medical Chart Review
  • Birmingham, Alabama
  • +240 more
Oct 19, 2022

Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)

Recruiting
  • Liposarcoma
  • +5 more
  • Eribulin Mesylate
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 17, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Behavioral Intervention, Interview,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Behavioral Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +43 more
  • Best Practice
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Chemo-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (drug,

Recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • +2 more
  • Houston, Texas
  • +1 more
Oct 6, 2022

Preliminary Testing of MD Anderson Symptom Inventory

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Interview
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Recruiting
  • COVID-19 Infection
  • Malignant Solid Neoplasm
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Solid Tumor Trial in Orland Park, Seattle (Nozin, Best Practice)

Suspended
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Orland Park, Illinois
  • +1 more
Sep 20, 2022

Interviews, Screening, Healthcare Workers Trial in Houston (First Interview, Second Interview, 8-week multicomponent

Recruiting
  • Anxiety Disorder
  • +2 more
  • Behavioral Intervention
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Prediction in Solid Tumors

Recruiting
  • Malignant Solid Neoplasm
  • Biospecimen Collection
  • Questionnaire Administration
  • Ames, Iowa
  • +5 more
Sep 7, 2022